Clinical trial
Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic Pain
NCT00301405 · Kenneth Peters, MD, Other · Terminated
Key facts
| NCT number | NCT00301405 |
|---|---|
| Title | Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic Pain |
| Official title | Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic Pain |
| Lead sponsor | Kenneth Peters, MD, Other |
| Collaborators | Celgene Corporation Industry Corewell Health East |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Prostatitis, Pelvic Pain |
| Intervention type | Drug |
| Interventions | Thalidomide |
| Enrollment | 9 |
| Start date | Mar 1, 2006 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Mar 10, 2006 |
| Last update posted | Aug 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: